Halozyme Therapeutics
HALO
#2343
Rank
S$9.59 B
Marketcap
S$81.30
Share price
0.25%
Change (1 day)
-4.92%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): S$0.97 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$1.24 Billion. In 2024 the company made an earning of S$0.71 Billion, an increase over its 2023 earnings that were of S$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.97 B37.01%
2024 S$0.71 B59.94%
2023 S$0.44 B39.94%
2022 S$0.31 B0.16%
2021 S$0.31 B92.2%
2020 S$0.16 B-278.96%
2019 -S$92.61 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$78.96 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$41.32 Million-52.86%
2014 -S$87.64 Million-18.09%
2013 -S$0.11 Billion55.88%
2012 -S$68.64 Million169.94%
2011 -S$25.43 Million-63.44%
2010 -S$69.55 Million-7.19%
2009 -S$74.93 Million15.91%
2008 -S$64.65 Million83.89%
2007 -S$35.16 Million78.1%
2006 -S$19.74 Million16%
2005 -S$17.02 Million45.24%
2004 -S$11.72 Million682.42%
2003 -S$1.5 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.52 B 4,242.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.19 B 1,488.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.84 B 2,916.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.66 B 1,119.98%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-S$0.35 Billion-136.20%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$39.45 M-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA